BioLife Solutions, Inc.
BLFS
$25.65
-$0.26-1.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.42M | 23.94M | -3.42M | 30.57M | 19.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.42M | 23.94M | -3.42M | 30.57M | 19.72M |
| Cost of Revenue | 8.99M | 8.16M | -11.70M | 14.28M | 6.51M |
| Gross Profit | 16.43M | 15.79M | 8.27M | 16.30M | 13.21M |
| SG&A Expenses | 14.13M | 14.10M | 5.80M | 14.89M | 11.80M |
| Depreciation & Amortization | 708.00K | 702.00K | 3.00K | 910.00K | 683.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.54M | 25.16M | -4.81M | 32.13M | 21.02M |
| Operating Income | -1.12M | -1.22M | 1.39M | -1.56M | -1.31M |
| Income Before Tax | -15.71M | -434.00K | 1.54M | -1.73M | -5.56M |
| Income Tax Expenses | 126.00K | 14.00K | -131.00K | -28.00K | 1.00K |
| Earnings from Continuing Operations | -15.84M | -448.00K | 1.67M | -1.70M | -5.56M |
| Earnings from Discontinued Operations | -- | -- | 10.79M | -- | -15.16M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.84M | -448.00K | 12.46M | -1.70M | -20.72M |
| EBIT | -1.12M | -1.22M | 1.39M | -1.56M | -1.31M |
| EBITDA | 260.00K | 166.00K | 2.76M | 758.00K | 1.06M |
| EPS Basic | -0.33 | -0.01 | 0.27 | -0.04 | -0.45 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.33 | -0.01 | 0.26 | -0.04 | -0.45 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 47.80M | 47.13M | 46.65M | 46.18M | 46.00M |
| Average Diluted Shares Outstanding | 47.80M | 47.13M | 48.03M | 46.18M | 46.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |